Skip to content

A Clinical Study on the Combination of Shuxian Anshen Formula and Micro-needle Acupuncture for the Treatment of Androgenetic Alopecia (Stagnation of Liver Qi Syndrome)

A Clinical Study on the Combination of Shuxian Anshen Formula and Micro-needle Acupuncture for the Treatment of Androgenetic Alopecia (Stagnation of Liver Qi Syndrome)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000604
Enrollment
Unknown
Registered
2024-10-23
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia

Interventions

control group:microneedle acupuncture

Sponsors

Shuguang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1) Patients who meet the diagnostic criteria of androgenic alopecia in Clinical Dermatology. 2) Patients who meet the criteria for syndrome differentiation of liver-qi stagnation with reference to "Traditional Chinese Surgery". 3) Age 18-50 years old gender is not limited; 4) Agree to participate in clinical trial observation and can cooperate with the regular interview.

Exclusion criteria

Exclusion criteria: 1) Those who do not meet the above inclusion criteria. 2) Pregnant and lactating women. 3) Patients with drug allergy in this study. 4) People with severe allergies. 5) Patients with severe cardiovascular and cerebrovascular diseases liver and kidney insufficiency blood system diseases autoimmune diseases and mental diseases. 6) Refuse to cooperate with the treatment accompanied by visitors.

Design outcomes

Primary

MeasureTime frame
Number of new hair;

Countries

China

Contacts

Public Contacthe xiang

Shuguang Hospital

heroxiang@hotmail.com13681737694

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026